4
Changes in Ownership
Lexeo Therapeutics, Inc. Filed Acc 0000950170-24-003466
Chief Executive Officer acquired 43,750 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Townsend Richard Nolan · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-01-05 | Grant or award : show line 1 in the form 10b5-1 | +43,750 | 170,695 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-01-05 | Grant or award : show line 2 in the form 10b5-1 Stock Option (Right to Buy) | +262,500 | 262,500 | D |
Loading xslF345X05/ownership.xml…